BlackRock
PASG icon

BlackRock’s Passage Bio PASG Stock Holding History

BlackRock’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Sell
27,910
-685
-2% -$4.29K ﹤0.01% 4928
2026
Q1 		$224K Sell
28,595
-308
-1% -$3.19K ﹤0.01% 4740
2025
Q4 		$341K Sell
28,903
-846
-3% -$7.3K ﹤0.01% 4587
2025
Q3 		$239K Buy
29,749
+6
+0% +$42 ﹤0.01% 4643
2025
Q2 		$238K Sell
29,743
-6,180
-17% -$45.2K ﹤0.01% 4624
2025
Q1 		$254K Sell
35,923
-192
-0.5% -$2.08K ﹤0.01% 4557
2024
Q4 		$410K Buy
36,115
+28
+0.1% +$365 ﹤0.01% 4462
2024
Q3 		$505K Sell
36,087
-4,789
-12% -$76.3K ﹤0.01% 4324
2024
Q2 		$649K Sell
40,876
-5,251
-11% -$128K ﹤0.01% 4278
2024
Q1 		$1.25M Sell
46,127
-5,001
-10% -$120K ﹤0.01% 4138
2023
Q4 		$1.03M Buy
51,128
+512
+1% +$7.07K ﹤0.01% 4243
2023
Q3 		$666K Sell
50,616
-2,145
-4% -$35.2K ﹤0.01% 4343
2023
Q2 		$993K Buy
52,761
+61
+0.1% +$1.21K ﹤0.01% 4297
2023
Q1 		$1.01M Sell
52,700
-3,485
-6% -$94.5K ﹤0.01% 4334
2022
Q4 		$1.55M Sell
56,185
-11,012
-16% -$278K ﹤0.01% 4245
2022
Q3 		$1.68M Sell
67,197
-1,220
-2% -$48.1K ﹤0.01% 4277
2022
Q2 		$3.23M Sell
68,417
-96,223
-58% -$4.49M ﹤0.01% 4017
2022
Q1 		$10.2M Sell
164,640
-9,938
-6% -$819K ﹤0.01% 3566
2021
Q4 		$22.2M Buy
174,578
+18,677
+12% +$3.05M ﹤0.01% 3212
2021
Q3 		$31.1M Buy
155,901
+838
+0.5% +$200K ﹤0.01% 2984
2021
Q2 		$41.1M Buy
155,063
+4,981
+3% +$1.54M ﹤0.01% 2831
2021
Q1 		$52.5M Buy
150,082
+39,397
+36% +$16.8M ﹤0.01% 2581
2020
Q4 		$56.6M Buy
110,685
+35,022
+46% +$14M ﹤0.01% 2396
2020
Q3 		$19.8M Buy
75,663
+5,322
+8% +$1.83M ﹤0.01% 2861
2020
Q2 		$38.4M Buy
70,341
+39,352
+127% +$17.7M ﹤0.01% 2402
2020
Q1 		$9.76M Buy
+30,989
New +$9.69M ﹤0.01% 3008

Other funds holding PASG

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM

BlackRock's PASG Position: Q2 2026 in Review

BlackRock reduced its Passage Bio (PASG) stake by 2.4% in Q2 2026, selling an estimated $4.29K and leaving 27,910 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #4928.

BlackRock first reported a position in PASG in Q1 2020 and has held it in 26 quarters since. The position peaked at $56.6M in Q4 2020. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • BlackRock held 27,910 shares of Passage Bio worth $136K as of Q2 2026.
  • BlackRock sold 685 Passage Bio shares in Q2 2026, an estimated $4.29K.
  • Passage Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4928 holding.
  • BlackRock first reported a position in Passage Bio in Q1 2020 and has held it in 26 quarters since.
  • BlackRock's Passage Bio position peaked at $56.6M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.